Showing results (21-30 of 269) with videos related to
Sort By:
Pageof 27
Expert Review of Vaccines|February 7, 2007
Development of vaccines for Marburg hemorrhagic feverDaniel G Bausch, Thomas W GeisbertExpert Reviews in Molecular Medicine|September 24, 2004
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventionsThomas W Geisbert, Lisa E HensleyTrends in Molecular Medicine|July 13, 2017
Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the LoopChad E Mire, Thomas W GeisbertNPJ Vaccines|January 3, 2026
A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challengeDeclan D Pigeaud, Viktoriya Borisevich, Krystle N Agans, et al.Thrombosis and Haemostasis|August 23, 2005
The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primatesLisa E Hensley, Thomas W GeisbertMethods in Molecular Biology (Clifton, N.J.)|June 3, 2017
Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate ModelsChad E Mire, Thomas W GeisbertNature|January 7, 2026
Oral 4'-fluorouridine rescues nonhuman primates from advanced Lassa feverRobert W Cross, Jacquelyn Turcinovic, Abhishek N Prasad, et al.Expert Review of Vaccines|December 18, 2010
Progress in filovirus vaccine development: evaluating the potential for clinical useDarryl Falzarano, Thomas W Geisbert, Heinz FeldmannThe Journal of Infectious Diseases|June 26, 2018
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman PrimatesCourtney Woolsey, Joan B Geisbert, Demetrius Matassov, et al.Current Opinion in Virology|February 14, 2013
Animal models for highly pathogenic emerging virusesDavid Safronetz, Thomas W Geisbert, Heinz FeldmannPageof 27